resources

Gujarat Inject (Kerala) Ltd.

BSE: 524238

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

10.50+0.5 (+5.00%)

7 Aug, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Gujarat Inject (Kerala) Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	—
Quarterly Results	—	—	—	—	Mar Jun Sept	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Gujarat Inject (Kerala) Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

EGM16 Jul 2026
01/2026-27 Extra Ordinary General Meeting ('EGM') Of The Members Of The Company Is Scheduled To Be Held On Wednesday, 12Th August, 2026 At 03.30 P.M
01/2026-27 Extra Ordinary General Meeting of the Company will be held on 12.08.2026 at 3:30 PM through VC/OAVM.
Press Release / Media Release15 Jul 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release Issued by Company.
Outcome of Board Meeting15 Jul 2026
Board Meeting Outcome for OUTCOME OF BOARD MEETING
APPROVAL OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED ON 30.06.2026.
Amendments to Memorandum & Articles of Association14 Jul 2026
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Alteration of Memorandum and Articles of association pursuant to the Change of name of the Company.
Board Meeting10 Jul 2026
Board Meeting Intimation for Consideration And Approval Of Financial Results.
Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/07/2026 ,inter alia, to consider and approve consideration and approval ....
Reg.24(A)-Annual Secretarial Compliance9 Jul 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance for March 2026
Change in Management6 Jul 2026
Announcement under Regulation 30 (LODR)-Change in Management
To appoint Mr. Murli Shivshankaran Nair as an additonal Dirctor designated as Managing Director of the company
Press Release / Media Release6 Jul 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are enclosing Media Release on Stock Split, Financial Growth and Recent Major Solar Order.
Closure of Trading Window30 Jun 2026
Closure of Trading Window
Closure of Trading Window for the Declaration of Financial Results of the First Quarter ended 30th June, 2026.
Sub-division / Stock Split29 Jun 2026
Corporate Action-updates on Outcome of Sub division / Stock Split
Revision in Record Date for Sub-Division/Split of Equity Shares.
Sub-division / Stock Split27 Jun 2026
Corporate Action-Outcome of Sub division / Stock Split
The Company has fixed Thursday, 02.07.2026 as the Record Date for determining the eligibilty of shareholders entitled to receive the benefit of sub-division (stock split) of Equity Shares ....
Cessation24 Jun 2026
Announcement under Regulation 30 (LODR)-Cessation
Intimaion of sad demise of Mr. Deepak Diwan Bachwani, whole time director, Chief Financial Officer and Chairman of the company on 23rd June, 2026
Press Release / Media Release15 Jun 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are enclosing Press Release on receipt of Purchase Order from Deon Energy Limited.
Award of Order / Receipt of Order11 Jun 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
The company has received a Purchase order from DEON ENERGY LIMITED for 16,129 NOS Solar PV Module. Total Value is around 14.49 Crores (exclusive of GST).
Award of Order / Receipt of Order8 Jun 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
The Company has received a Purchased Order from OTTRIVE LIFESTYLE PRIVATE LIMITED for 1334 NOS Solar PV Module. The Total Value is around 1.07 Crores (exclusive of GST).
Press Release / Media Release25 May 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Media Release on Audited Financial for Results for Q4 FY26.
Outcome of Board Meeting20 May 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday, 20Th May, 2026 And Submission Of Audited Financial Results (Standalone) For The Fourth Quarter And Year Ended On 31St March, 2026
Pursuant to Regulations 30, 33 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors ....
Change in Directorate16 May 2026
Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Whole Time Director and Chairman of the company w.e.f. 16/05/2026.
Resignation of Chairman and Managing Director16 May 2026
Announcement under Regulation 30 (LODR)-Resignation of Chairman and Managing Director
Resignation of Managing Director and chairman of the company w.e.f. 16/05/2026.
Board Meeting15 May 2026
Board Meeting Intimation for Board Meeting For Consideration Of Audited Financial Results For The Quarter & Year Ended 31St March, 2026.
Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve 1. Audited Standalone ....

Frequently Asked Questions

Where can I download the annual report of Gujarat Inject (Kerala) Ltd.?

Annual reports of Gujarat Inject (Kerala) Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Gujarat Inject (Kerala) Ltd.?

Quarterly earnings results and presentations of Gujarat Inject (Kerala) Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Gujarat Inject (Kerala) Ltd. publish earnings call transcripts?

Earnings call transcripts of Gujarat Inject (Kerala) Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Gujarat Inject (Kerala) Ltd.?

Investor presentations and annual day presentations of Gujarat Inject (Kerala) Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Gujarat Inject (Kerala) Ltd.?

Corporate announcements and regulatory filings of Gujarat Inject (Kerala) Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Gujarat Inject (Kerala) Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Gujarat Inject (Kerala) Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Gujarat Inject (Kerala) Ltd.?

The ISIN (International Securities Identification Number) of Gujarat Inject (Kerala) Ltd. is INE659F01022. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Gujarat Inject (Kerala) Ltd. listed?

Gujarat Inject (Kerala) Ltd. is listed on NSE and BSE. The NSE symbol is GUJINJEC and the BSE code is -.

Where can I find the shareholding pattern of Gujarat Inject (Kerala) Ltd.?

The quarterly shareholding pattern of Gujarat Inject (Kerala) Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Gujarat Inject (Kerala) Ltd. on Sharpely?

Share price data for Gujarat Inject (Kerala) Ltd. is updated as of 7 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.